Pressure Therapy in the Treatment of Upper Arm of Cerebral Palsy Children
NCT ID: NCT02086214
Last Updated: 2025-12-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
101 participants
INTERVENTIONAL
2012-12-21
2021-04-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Proprioceptive pressure therapy
Proprioceptive pressure therapy using a a LYCRA® compressive sleeve initially used in burn therapy : 15 to 25 mmHg.
Proprioceptive pressure therapy
Proprioceptive pressure therapy using a a LYCRA® compressive sleeve initially used in burn therapy : 15 to 25 mmHg.
Control
LYCRA® non-compressive sleeve initially used in burn therapy : \< 5 mmHg.
Control
LYCRA® non-compressive sleeve initially used in burn therapy : \< 5 mmHg.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Proprioceptive pressure therapy
Proprioceptive pressure therapy using a a LYCRA® compressive sleeve initially used in burn therapy : 15 to 25 mmHg.
Control
LYCRA® non-compressive sleeve initially used in burn therapy : \< 5 mmHg.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Children aged 5 to 10 years
Exclusion Criteria
* LYCRA® allergia
* Botulic Toxin injection on upper limb 4 month before inclusion
5 Years
10 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Marc Sautelet Centre (Villeneuve d'Ascq, France)
UNKNOWN
University Hospital, Lille
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Laurent GOTTRAND, MD
Role: PRINCIPAL_INVESTIGATOR
Centre Marc Sautelet, Villeneuve d'Ascq, France
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU
Amiens, , France
Service d'Education et de Soins Spécialisés à domicile_APF de Creil
Creil, , France
CHU
Reims, , France
Centre de Soins de Suite et de Réadaptation Pédiatrique Spécialisé_Centre Paul Dottin
Toulouse, , France
Centre Marc Sautelet
Villeneuve-d'Ascq, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Gerard A, Toussaint-Thorin M, Mohammad Y, Letellier G, Fritot S, Masson S, Duhamel A, Donskoff C, Zagame Y, Beghin L, Gottrand L. PROPENSIX: pressure garment therapy using compressive dynamic Lycra(R) sleeve to improve bi-manual performance in unilateral cerebral palsy: a multicenter randomized controlled trial protocol. Trials. 2022 Feb 5;23(1):117. doi: 10.1186/s13063-022-06041-1.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
N°19/16, Axe 1.11,
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
2011-A01129-32
Identifier Type: OTHER
Identifier Source: secondary_id
2011_01
Identifier Type: -
Identifier Source: org_study_id